Clinical utility of ypTNM stage grouping in the 8th edition of the American joint committee on cancer TNM staging system for esophageal squamous cell carcinoma
N Sudo, H Ichikawa, Y Muneoka, T Hanyu… - Annals of Surgical …, 2021 - Springer
Background The 8th edition of the American Joint Committee on Cancer (AJCC) TNM
staging system provided a specific 'ypTNM'stage grouping for patients with esophageal …
staging system provided a specific 'ypTNM'stage grouping for patients with esophageal …
The 8th edition of the AJCC-TNM classification: New contributions to the staging of esophagogastric junction cancer
JE Sos, LG Quiles, K Maiocchi - Cirugía Española (English Edition), 2019 - Elsevier
The new 8th edition of the TNM classification system for esophageal and cardia or
esophagogastric junction cancer provides important innovations in the TNM stages. Two …
esophagogastric junction cancer provides important innovations in the TNM stages. Two …
Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
JK Yun, Y Kim, GD Lee, S Choi, YH Kim… - Cancer …, 2022 - Wiley Online Library
Introduction We aimed to elucidate the prognostic value of tumor regression grade (TRG)
combined with lymph node status compared with the 8th edition of the ypTNM staging …
combined with lymph node status compared with the 8th edition of the ypTNM staging …
[HTML][HTML] Recurrence timing and patterns incorporating lymph node status after neoadjuvant chemoradiotherapy plus esophagectomy for esophageal squamous cell …
G Liu, B Hu, T Chen, X Zhang, Y Tang, Q Chen… - Frontiers in …, 2024 - frontiersin.org
Purpose About 40% of esophageal squamous cell carcinoma (ESCC) patients experienced
recurrence after neoadjuvant chemoradiotherapy (nCRT) plus esophagectomy. While …
recurrence after neoadjuvant chemoradiotherapy (nCRT) plus esophagectomy. While …
Validation of the post-neoadjuvant staging system of the American joint committee on cancer, in patients treated with neoadjuvant chemoradiotherapy followed by …
J Kang, HP Lee, HR Kim, JH Kim, HY Jung, GH Lee… - Surgical Oncology, 2020 - Elsevier
Abstract Objective The American Joint Committee on Cancer 8th edition staging system
presents separate classifications for pTNM and post-neoadjuvant ypTNM (ypTNM-8th) to …
presents separate classifications for pTNM and post-neoadjuvant ypTNM (ypTNM-8th) to …
Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy …
T Oshikiri, H Goto, T Kato, R Sawada, H Harada… - European Journal of …, 2022 - Elsevier
Background The eighth edition of the American Joint Committee on Cancer (AJCC) tumor
node metastasis (AJCC-TNM 8th) system adopted the newly separate post-neoadjuvant …
node metastasis (AJCC-TNM 8th) system adopted the newly separate post-neoadjuvant …
[HTML][HTML] Expert elicitation to inform a cost-effectiveness analysis of screening for renal cancer
Background Population screening for renal cell carcinoma (RCC) using ultrasound has the
potential to improve survival outcomes; however, a cost-effectiveness analysis (CEA) has yet …
potential to improve survival outcomes; however, a cost-effectiveness analysis (CEA) has yet …
[HTML][HTML] Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer
E Bollschweiler, AH Hölscher - Annals of Translational Medicine, 2019 - ncbi.nlm.nih.gov
In recent years, pre and perioperative chemotherapy or chemoradiotherapy have been
successfully implemented for advanced esophageal carcinoma (1, 2). Traditionally, the …
successfully implemented for advanced esophageal carcinoma (1, 2). Traditionally, the …
Proper prognostic classification of histopathologic response to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
G Liu, X Zhang, T Chen, Y Tang, B Hu, H Shi - 2023 - researchsquare.com
Background Accurate restaging and histological assessment of esophageal squamous cell
carcinoma (ESCC) after neoadjuvant chemoradiotherapy (nCRT) provide valuable …
carcinoma (ESCC) after neoadjuvant chemoradiotherapy (nCRT) provide valuable …
[HTML][HTML] Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy
M Osecky, D Kröll, M Feith, D Reim, B Dislich… - Gastrointestinal …, 2020 - mdpi.com
Tumor regression following neoadjuvant treatment can be observed in lymph node (LN)
metastases similar to the primary tumor in esophageal adenocarcinomas (EAC). We …
metastases similar to the primary tumor in esophageal adenocarcinomas (EAC). We …